- uplisting wasn't mentioned as a near-term milest
Post# of 30028
Posted On: 12/02/2014 2:23:28 PM
- uplisting wasn't mentioned as a near-term milestone and mentioned only briefly - we're"preparing to uplist". Possibly because this was a short presentation and the emphasis was intended to be on the pipeline and science. Or maybe seeming eager to get off the OTC doesn't help their lympro negotations?
- in "several discussions" re: lympro monetization.
- in "several discussions" re: lympro monetization.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼